We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Anagni

News List

Catalent Plans $100M Expansion of Biologics Mfg. Capabilities in Italy contractpharma
July 22, 2021
Initial phase includes installation of two 2,000-liter single-use bioreactors and associated investments to support early-and late-phase clinical development.
Catalent plans $100 million biologics manufacturing expansion at Anagni cphi-online
July 22, 2021
Two 2,000-liter single-use bioreactors to be installed as part of first phase expected to be operational in April 2023
AstraZeneca Releases Statement on COVID-19 Vaccine Supply at Anagni Plant in Italy americanpharmaceuticalreview
April 02, 2021
The following is a statement from AstraZeneca regarding the company’s vaccine supply at their Anagni Plant in Italy.
Bristol-Myers Squibb completes divestment of manufacturing facility in Anagni, Italy worldpharmanews
January 09, 2020
Bristol-Myers Squibb Company (NYSE:BMY) announced today that it has completed its previously announced divestment of its oral solid, biologics, and sterile product manufacturing and ...
Catalent to Purchase BMS Mfg. Facility in Anagni, Italy contractpharma
June 20, 2019
Catalent will continue to manufacture BMS products while offering access to sterile biologics fill/finish and oral solids manufacturing and packaging platforms.